Literature DB >> 3343048

Antibacterial activity of recombinant murine beta interferon.

T Fujiki1, A Tanaka.   

Abstract

Recombinant murine beta interferon was protective and therapeutic for mice against Listeria monocytogenes infection in vivo. The recombinant murine beta interferon caused enhanced H2O2 release by macrophages in vivo, but not in vitro.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3343048      PMCID： PMC259324          DOI： 10.1128/iai.56.3.548-551.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  23 in total

1.  Three phases of phagocyte contribution to resistance against Listeria monocytogenes.

Authors:  M Mitsuyama; K Takeya; K Nomoto; S Shimotori
Journal:  J Gen Microbiol       Date:  1978-05

2.  Structure and expression of a cloned cDNA for mouse interferon-beta.

Authors:  Y Higashi; Y Sokawa; Y Watanabe; Y Kawade; S Ohno; C Takaoka; T Taniguchi
Journal:  J Biol Chem       Date:  1983-08-10       Impact factor: 5.157

3.  Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice.

Authors:  G Bukholm; B P Berdal; C Haug; M Degré
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

4.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.

Authors:  A F Kiderlen; S H Kaufmann; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

5.  Effect of a homologous beta-interferon preparation on degradation of Escherichia coli and on lysosomal enzyme activities in mouse peritoneal macrophages.

Authors:  H Rollag; B Mørland; M Degré
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1982-04

6.  Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.

Authors:  D Boraschi; P Ghezzi; E Pasqualetto; M Salmona; L Nencioni; D Soldateschi; L Villa; A Tagliabue
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

7.  The significance of alpha/beta interferons and gamma interferon produced in mice infected with Listeria monocytogenes.

Authors:  A Nakane; T Minagawa
Journal:  Cell Immunol       Date:  1984-10-01       Impact factor: 4.868

8.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

9.  Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization.

Authors:  E Wang; J Michl; L M Pfeffer; S C Silverstein; I Tamm
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539
View more
  9 in total

Review 1.  Use of immune modulators in nonspecific therapy of bacterial infections.

Authors:  M T Vogels; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.

Authors:  M Denis
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component.

Authors:  A Sing; T Merlin; H P Knopf; P J Nielsen; H Loppnow; C Galanos; M A Freudenberg
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Enhanced resistance against Escherichia coli infection by subcutaneous administration of the hot-water extract of Chlorella vulgaris in cyclophosphamide-treated mice.

Authors:  F Konishi; K Tanaka; S Kumamoto; T Hasegawa; M Okuda; I Yano; Y Yoshikai; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Recombinant interleukin-6 protects mice against experimental bacterial infection.

Authors:  Z Liu; R J Simpson; C Cheers
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages.

Authors:  P Utaisincharoen; N Anuntagool; K Limposuwan; P Chaisuriya; S Sirisinha
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Role of beta interferon in resistance to Toxoplasma gondii infection.

Authors:  M A Orellana; Y Suzuki; F Araujo; J S Remington
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Cell-Based Screen Identifies Human Interferon-Stimulated Regulators of Listeria monocytogenes Infection.

Authors:  Sofya S Perelman; Michael E Abrams; Jennifer L Eitson; Didi Chen; Alyssa Jimenez; Marcel Mettlen; John W Schoggins; Neal M Alto
Journal:  PLoS Pathog       Date:  2016-12-21       Impact factor: 6.823

9.  Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

Authors:  A S Cross; J C Sadoff; N Kelly; E Bernton; P Gemski
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.